particularly in low- and medium-resourced countries. Professor You-Lin Qiao is Director of the Department of
Cancer Epidemiology at the Cancer Institute/Hospital of the
Dr Ramadas is trained in radiotherapy and clinical oncology Chinese Academy of Medical Sciences & Peking Union Medical
and is currently Additional Professor of Radiation Oncology and College, Beijing, China and Deputy Director of the National
Medical Superintendent, at the Regional Cancer Centre, Expert Committee for Cancer Screening and Prevention in
Trivandrum, India. He has a keen interest cancer prevention, China. He coordinates a large number of breast and cervical
early detection and control and co-ordinates large population cancer early detection studies in China and has contributed to
based breast and oral cancer screening trials in Kerala, India the development of validation of rapid, accurate and affordable
and several hospital-based phase II and phase III randomized HPV tests for early detection of cervical neoplasia. His research
clinical trials evaluating new therapeutic interventions in head efforts have led to the rolling out of large population-based
and neck and upper aero-digestive cancers. breast and cervical screening programmes in China.
Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia KS, Chen JG et al. Accuracy of human papillomavirus testing in primary screening of cervical neoplasia:
Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet results from a multicenter study in India. Int J Cancer 2004; 112(2):341-347.
Oncol 2010; 11(2):165-173. 14.
Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM et al.
Sankaranarayanan R, Swaminathan R. Cancer survival in Africa, Asia, the Caribbean HPV screening for cervical cancer in rural India. N Engl J Med 2009; 360(14):1385-
and Central America. IARC Scientific Publications No. 162. Lyon: International 1394.
Agency for Research on Cancer, 2011. 15.
Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L et al. Cervical
US National Cancer Institute. Surveillance Epidemiology and End Results (US SEER). cancer risk for women undergoing concurrent testing for human papillomavirus and
Available from: http://seer.cancer.gov. cervical cytology: a population-based study in routine clinical practice. Lancet Oncol
Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. 2011; 12(7):663-672.
Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Ponten J, Adami HO, Bergstrom R, Dillner J, Friberg LG, Gustafsson L et al. Strategies
Cancer 2009; 45(6):931-991. for global control of cervical cancer. Int J Cancer 1995; 60(1):1-26.
National cancer control programmes: policies and managerial guidelines. 2nd ed. Gustafsson L, Ponten J, Bergstrom R, Adami HO. International incidence rates of
Geneva: World Health Organization, 2002. invasive cervical cancer before cytological screening. Int J Cancer 1997; 71(2):159-
Sankaranarayanan R, Wesley RS. A practical manual on visual screening for cervical 165.
neoplasia. IARC Technical Publication No. 41. Lyon: International Agency for Reintgen D, Berman C, Cox C, Baekey P, Nicosia S, Greenberg H et al. The anatomy of
Research on Cancer, 2003. missed breast cancers. Surg Oncol 1993; 2(1):65-75.
Screening Group. International Agency for Research on Cancer. Available from: Mahoney L, Csima A. Efficiency of palpation in clinical detection of breast cancer. Can
http://screening.iarc.fr/. Med Assoc J 1982; 127(8):729-730.
Denny L, Kuhn L, Hu CC, Tsai WY, Wright TC, Jr. Human papillomavirus-based cervical Stockton D, Davies T, Day N, McCann J. Retrospective study of reasons for improved
cancer prevention: long-term results of a randomized screening trial. J Natl Cancer survival in patients with breast cancer in east Anglia: earlier diagnosis or better
Inst 2010; 102(20):1557-1567. treatment. BMJ 1997; 314(7079):472-475.
Blumenthal PD, Gaffikin L, Deganus S, Lewis R, Emerson M, Adadevoh S. Cervical Jatoi I, Anderson WF, Rao SR, Devesa SS. Breast cancer trends among black and white
cancer prevention: safety, acceptability, and feasibility of a single-visit approach in women in the United States. J Clin Oncol 2005; 23(31):7836-7841.
Accra, Ghana. Am J Obstet Gynecol 2007; 196(4):407-408. 22.
Khuhaprema T, Attasara P, Srivatanakul P, Sangrajrang S, Muwonge R, Sauvaget C et
Gaffikin L, Blumenthal PD, Emerson M, Limpaphayom K. Safety, acceptability, and al. Organization and evolution of organized cervical cytology screening in Thailand.
feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a Int J Gynaecol Obstet 2012; 118(2):107-111.
demonstration project. Lancet 2003; 361(9360):814-820. 23.
Sanghvi H, Limpaphayom KK, Plotkin M, Charurat E, Kleine A, Lu E et al. Cervical
Nessa A, Hussain MA, Rahman JN, Rashid MH, Muwonge R, Sankaranarayanan R. cancer screening using visual inspection with acetic acid: operational experiences
Screening for cervical neoplasia in Bangladesh using visual inspection with acetic from Ghana and Thailand. Reprod Health Matters 2008; 16(32):67-77.
acid. Int J Gynaecol Obstet 2010; 111(2):115-118. 24.
Chumworathayi B, Thinkhamrop J, Blumenthal PD, Thinkhamrop B, Pientong C,
Sankaranarayanan R, Esmy PO, Rajkumar R, Muwonge R, Swaminathan R, Ekalaksananan T. Cryotherapy for HPV clearance in women with biopsy-confirmed
Shanthakumari S et al. Effect of visual screening on cervical cancer incidence and cervical low-grade squamous intraepithelial lesions. Int J Gynaecol Obstet 2010;
mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet 2007; 108(2):119-122.
Editorial. Women’s health in rural China. Lancet 2009; 374(9687):358.
Sankaranarayanan R, Chatterji R, Shastri SS, Wesley RS, Basu P, Mahe C et al. 26.
Selvam J. Personal Communication. 2012.
72 CANCER CONTROL 2013